HALO:BMV
Halozyme Therapeutics, Inc.
MX$2,315.00
arrow_upward
+1.09%(+25.00) 1D
Oct 22, 2:00:00 PM GMT-6 · MXN
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HALO...
Open
MX$2,315.00
High
MX$2,315.00
Low
MX$2,315.00
Mkt. cap
14.14B
Avg. vol.
443.00
Volume
12.00
52-wk high
MX$2,315.00
52-wk low
MX$1,126.00
No. of employees
423
Open
MX$2,315.00
High
MX$2,315.00
Low
MX$2,315.00
Mkt. cap
14.14B
Avg. vol.
443.00
Volume
12.00
52-wk high
MX$2,315.00
52-wk low
MX$1,126.00
No. of employees
423
News stories
From web sources and news partners
Yahoo Finance
·
22 hours ago
Halozyme to Report Third Quarter 2026 Financial and Operating Results
Trefis
·
1 day ago
Halozyme Therapeutics Stock: 6 Straight Green Days, Up 14%
Profile
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. Wikipedia
About Halozyme Therapeutics, Inc.
CEOHelen I. Torley
Employees423
Founded1998
HeadquartersSan Diego, California, United States
SectorBiotechnology
Websitehalozyme.com